Bid to fund blood test tool for liver fibrosis
It will help GPs sort out patients who need specialist referral, conference told
A blood test for liver fibrosis could help GPs risk-stratify the growing number of patients with non-alcoholic fatty liver disease, a conference has heard.
The Medical Services Advisory Committee (MSAC) is deciding whether to fund Hepascore, a four-biomarker blood test and prognostic tool developed in Perth, for all patients with chronic liver disease.
